NanoViricides (NNVC) Stock Chart & Stock Price History $1.57 -0.01 (-0.63%) As of 10:01 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NanoViricides Stock Price Performance The NanoViricides (NNVC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 25.24%, with a year-to-date return of 9.79%. In the past month, the stock has increased 12.14%, reflecting recent market activity. As of the latest close, NanoViricides traded at $1.58 with a market cap of $25.39 million and volume of 179,280 shares. Receive NNVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.55%1 Month Performance+12.14%3 Month Performance+20.77%Year-To-Date Performance+9.79%1 Year Performance-25.24% NNVC Stock Chart for Monday, August, 4, 2025 NNVC Chart by TradingView NanoViricides Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$1.62$1.58-2.47%$1.62$1.56179,280 shs$25.39 million07/31/2025$1.68$1.62-3.57%$1.70$1.61146,570 shs$26.04 million07/30/2025$1.70$1.68-1.18%$1.72$1.66331,796 shs$27.00 million07/29/2025$1.70$1.70$1.71$1.66230,862 shs$27.32 million07/28/2025$1.68$1.70+1.19%$1.71$1.65154,757 shs$27.32 million07/25/2025$1.71$1.68-1.75%$1.75$1.65170,240 shs$27.00 million07/24/2025$1.75$1.71-2.29%$1.77$1.66158,324 shs$27.48 million07/23/2025$1.70$1.75+2.94%$1.79$1.68651,787 shs$28.13 million07/22/2025$1.69$1.70+0.59%$1.70$1.66295,527 shs$27.32 million07/21/2025$1.68$1.69+0.60%$1.70$1.541.21 million shs$27.16 million Get the Latest News and Ratings for NNVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$1.64$1.68+2.44%$1.70$1.64251,444 shs$27.00 million07/17/2025$1.60$1.64+2.50%$1.70$1.60338,506 shs$26.36 million07/16/2025$1.46$1.60+9.59%$1.70$1.50557,051 shs$25.72 million07/15/2025$1.60$1.46-8.75%$1.61$1.46260,263 shs$23.47 million07/14/2025$1.40$1.60+14.70%$1.61$1.41632,344 shs$25.72 million07/11/2025$1.41$1.40-1.06%$1.40$1.37121,721 shs$22.42 million07/10/2025$1.40$1.41+0.71%$1.42$1.36109,085 shs$22.66 million07/09/2025$1.39$1.40+0.72%$1.42$1.34172,867 shs$22.50 million07/08/2025$1.38$1.39+0.72%$1.42$1.37132,265 shs$22.34 million07/07/2025$1.40$1.38-1.43%$1.42$1.37176,804 shs$22.18 million07/04/2025$1.40$1.40$1.44$1.35141,523 shs$22.18 million07/03/2025$1.39$1.40+0.72%$1.44$1.35141,523 shs$22.50 million Related Companies TScan Therapeutics Stock Price Chart Atossa Genetics Stock Price Chart MacroGenics Stock Price Chart HilleVax Stock Price Chart Immunic Stock Price Chart Zentalis Pharmaceuticals Stock Price Chart ANIXA BIOSCIENCES Stock Price Chart OKYO Pharma Stock Price Chart Oncolytics Biotech Stock Price Chart ImmunoPrecise Antibodies Stock Price Chart Receive NNVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NNVC) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
